A preservative composition is provided and includes polylysine, shagbark hickory bark extract, honeysuckle and citric extract(s).

Exercise is a stressor that is known to in some cases suppress antimicrobial protein levels, particularly secretory immunoglobulin type A (IgA). Athletes in the midst of in-season training often demonstrate low levels of sIgA and supplements may enhance post exercise mucosal immune function. A study was conducted where three treatments were administered (botanical spray, botanical drops, placebo) at the onset of 30 minutes of 80% V02 max cycle ergometer exercise. Secretory IgA and Human Alpha Defensin were quantified in saliva samples 30 minutes and 90 minutes post exercise. Analysis revealed a significant treatment effect at 30 min (p=0.030) with post hoc testing revealing a difference between the botanical spray and placebo (p=0.027), but by 90 minutes there was no differences by treatment (p=0.758). Based upon this study, it appears that a single dose of the tested botanical can provide enhanced mucosal immune capability for a short time post exercise.

Exercise is a stressor that is known to in some cases suppress antimicrobial protein levels, particularly secretory immunoglobulin type A (IgA). Athletes in the midst of in-season training often demonstrate low levels of sIgA and supplements may enhance post exercise mucosal immune function. A study was conducted where three treatments were administered (botanical spray, botanical drops, placebo) at the onset of 30 minutes of 80% V02 max cycle ergometer exercise. Secretory IgA and Human Alpha Defensin were quantified in saliva samples 30 minutes and 90 minutes post exercise. Analysis revealed a significant treatment effect at 30 min (p=0.030) with post hoc testing revealing a difference between the botanical spray and placebo (p=0.027), but by 90 minutes there was no differences by treatment (p=0.758). Based upon this study, it appears that a single dose of the tested botanical can provide enhanced mucosal immune capability for a short time post exercise.

Exercise is a stressor that is known to in some cases suppress antimicrobial protein levels, particularly secretory immunoglobulin type A (IgA). Athletes in the midst of in-season training often demonstrate low levels of sIgA and supplements may enhance post exercise mucosal immune function. A study was conducted where three treatments were administered (botanical spray, botanical drops, placebo) at the onset of 30 minutes of 80% V02 max cycle ergometer exercise. Secretory IgA and Human Alpha Defensin were quantified in saliva samples 30 minutes and 90 minutes post exercise. Analysis revealed a significant treatment effect at 30 min (p=0.030) with post hoc testing revealing a difference between the botanical spray and placebo (p=0.027), but by 90 minutes there was no differences by treatment (p=0.758). Based upon this study, it appears that a single dose of the tested botanical can provide enhanced mucosal immune capability for a short time post exercise.

Compositions comprising thermo-modified nutshells, for example hazelnut shells, are described herein. The compositions can also comprise one or more feed additives, pharmaceutically acceptable diluents and/or excipients. Also included are methods for producing the thermo-modified nutshell compositions, and methods for using the compositions to treat diarrhea and adsorb toxins as well as promote growth and improve the overall health in humans and other animals.

Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.

Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.